Teva Pharmaceutical Business Process Managment – Course Note – louai
Search
Essays
Sign up
Sign in
Contact us
Tweet
Index
/Business
Teva Pharmaceutical Business Process Managment
TEVA PharmaceuticalCompany OverviewTeva Pharmaceutical Industries Ltd is a global pharmaceutical company specializing in the development, production and marketing of generic[1] and branded pharmaceuticals as well as active pharmaceutical ingredients. The company head quarter at Israel, the company total sales count for US $ 13.9 Billion in 2009 with growth exceed 25%; North America and Europe sales represent 80% of company sales. 35’000 employees are working for Teva and the company has production facilities in Israel, North America, Europe and Latin America. Teva is ranked 15 among different pharmaceutical companies and considered the largest generic pharmaceutical company in the world.TEVA main activities:The company scope of activities includes manufacturing and marketing of products in the following categories: Human pharmaceuticals, Teva produces generic drugs in all major therapeutics areas and in different dosages forms, sterile, tablets and capsules, ointments, creams and liquids. Active Pharmaceutical Ingredients (API), Teva is a leading global supplier of Active Pharmaceutical Ingredients, Teva distribute its APIs to different manufacturing facilities and pharmaceutical manufacturers worldwide, this represent one of the core activities that account for 90% of Teva total sales. TEVA Partnership and intellectual property:Teva intellectual property has been built by partnership with different institution and small companies, and this allow Teva to have more than 3600 registered and patent records, 90% of submitted patents had being granted. Teva offer smaller companies and academic institutions access to resources, and strive to be partner of choice, they create a win-win situation for both Teva and their partners. Since the beginning of 2010, Teva has received 206 generic approvals in Europe relating to 64 compounds in 135 formulations, including three EMA (European Medicines Agency) approvals valid in all EU member states. In addition, as of March 31, 2010, Teva had approximately 3,207 marketing authorization applications pending approval in 30 European countries, relating to 242 compounds in 474 formulations, including six applications pending with the EMA. Teva had 210 product applications awaiting final FDA approval.Expansion through Acquisitions:Teva ‘went through the European markets via acquisitions , it’s start with the Dutch company Pharmachemie B.V then GRY-Pharm, APS/Berk , Biogal and others. Through these acquisitions, Teva has successfully established a network of subsidiaries across Europe. In the year 2000, Tevas acquired Novopharm in Canada. In 2002 of Teva acquired Bayer in France and Honeywell Fine Pharmaceutical Chemical plants in northern Italy. On January 22, 2004, Teva acquired Sicor Pharmaceuticals. In 2006, Teva acquired IVAX which expanded product lines in generics. In December 2008, Teva has completed its acquisition of Barr Pharmaceuticals in the US and its European subsidiary Pliva. In 2010 Teva has an agreement to acquire ratiopharm, an important milestone , that  will make Teva – the global generics leader and –“ the leader in Europe as well.”Stock Market:Teva is trade its shares on the Tel Aviv Stock Exchange and also traded on Seaq International in London and the Frankfurt Stock Exchange. Key financial figures:Quarterly net sales of $3.7 billion, up 16%, compared to the comparable period in 2009.

Continue for 2 more pages »
Read full document
Download as (for upgraded members)
Citation Generator
MLA 7
CHICAGO
(2017, 05). Teva Pharmaceutical Business Process Managment. EssaysForStudent.com. Retrieved 05, 2017, from
“Teva Pharmaceutical Business Process Managment” EssaysForStudent.com. 05 2017. 2017. 05 2017 < "Teva Pharmaceutical Business Process Managment." EssaysForStudent.com. EssaysForStudent.com, 05 2017. Web. 05 2017. < "Teva Pharmaceutical Business Process Managment." EssaysForStudent.com. 05, 2017. Accessed 05, 2017. Essay Preview By: louai Submitted: May 21, 2017 Essay Length: 539 Words / 3 Pages Paper type: Course Note Views: 447 Report this essay Tweet Related Essays Business Process Re-Engineering 1. FUNCTIONAL TACTICS Functional tactics are the key, routine activities that must be undertaken in each functional area that is human resource management, marketing, finance, 6,418 Words  |  26 Pages Business Process Management Business Process Management or BPM, is the practice of improving the efficiency and effectiveness of any organization by automating the organization's business processes. BPM 1,070 Words  |  5 Pages Operations in Supply Chain Management: What Process Management Can Do for a Company Running Head: OPERATIONS IN SUPPLY CHAIN MANAGEMENT Operations in Supply Chain Management What Process Management can do for a Company Edward Wanalista Operations Management ASCI 2,670 Words  |  11 Pages A Comprehensive Analysis of Oil & Gas Organizations Undergoing Erp Implementation: Business Processes Modelling and Risk Management [1] A Comprehensive Analysis of Oil & Gas Organizations undergoing ERP Implementation: Business Processes Modelling and Risk Management Harsha Sinha, Samrat Roy Choudhury Indian Institute 9,401 Words  |  38 Pages Similar Topics Business Process Reengineering IIBM Institute Business Management case Get Access to 89,000+ Essays and Term Papers Join 209,000+ Other Students High Quality Essays and Documents Sign up © 2008–2020 EssaysForStudent.comFree Essays, Book Reports, Term Papers and Research Papers Essays Sign up Sign in Contact us Site Map Privacy Policy Terms of Service Facebook Twitter

Get Your Essay

Cite this page

Teva Pharmaceutical Business Process Managment And Global Pharmaceutical Company. (July 3, 2021). Retrieved from https://www.freeessays.education/teva-pharmaceutical-business-process-managment-and-global-pharmaceutical-company-essay/